A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)

Abroad (travel likely)RecruitingPHASE2

Conditions

Chronic Hepatitis B

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

AusperBio Investigational Site, Jilin City, Changchun, China
Lu · clinicaltrial@ausperbio.com · 0571-86959519

Study leads

Junqi Niu
Principal Investigator
The First Hospital of Jilin University
Yanhua Ding
Principal Investigator
The First Hospital of Jilin University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection

Chronic Hepatitis B Virus Infection

Abroad (travel likely)RecruitingPHASE2

Chongqing, China

A Study of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver Fibrosis

Chronic Hepatitis B-related Liver Fibrosis

Abroad (travel likely)RecruitingPHASE2

Chongqing, China

A Study to Evaluate the Safety of Hydronidone Capsules in Patients With Liver Fibrosis

Chronic Hepatitis B With Hepatic Fibrosis

Abroad (travel likely)RecruitingPHASE2

Jilin City, China

A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Patients Treated for Chronic Hepatitis B

Chronic Hepatitis B

Abroad (travel likely)RecruitingPHASE2

Guangzhou, China